Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Faculty of Health Sciences

Department of Medicine

images of people within the metabolic bone disease fellowship
a collage of images of people within the metabolic bone disease fellowship
a collage of images of people within the metabolic bone disease fellowship
Dr Alalawi and Khan smiling

Endocrinology & Metabolism – Metabolic Bone Disease Fellowship

METABOLIC BONE DISEASE

Fellowship Program at McMaster

Welcome to the Metabolic Bone Disease Fellowship Program at McMaster University.

Welcome

The fellowship in Metabolic Bone Disease is a 1-year clinical research program. Successful completion of the program will enable the fellow to evaluate, diagnose, and provide evidence-based management of complex metabolic bone diseases. These include osteoporosis in pre and postmenopausal women as well as in men, fibrous dysplasia, sclerotic bone diseases, osteomalacia, osteogenesis imperfecta, hypophosphatasia, X-linked hypophosphatemia, renal osteodystrophy and Paget’s disease.

The fellow will also gain competence in evaluating complex calcium and parathyroid disorders as well as an understanding of how and when to complete genetic testing for calcium disorders as well as metabolic bone diseases. The fellow will attend the American Society of Bone and Mineral Research annual scientific meeting and submit research for presentation at this meeting. The fellowship curriculum is outlined in the American Society of Bone and Mineral Research Primer. It is expected that the fellow will gain this knowledge and the clinical skills to implement this knowledge in clinical practice. The fellow will attend the International Society of Clinical Densitometry certification course and obtain ISCD certification in the interpretation of BMD studies. It is expected that the fellow will be involved in clinical research and present at the ASBMR annual scientific meeting as well as at the ISCD annual scientific meeting.

Certification Outcome

Successful completion of the fellowship will provide the fellow with a McMaster University certificate confirming competence in Metabolic Bone Disease.

Entry Requirements

Requirements – certification in Endocrinology and Metabolism.

Application Deadline

9 months prior to starting date.

Present & Past Fellows:

  • Dr. Farah Al-Sarraf – September 2021.
  • Dr. Khulod Almonaei – September 2021 – August 2022.
  • Dr. Dalal S. Ali – September 2020 – August 2023.
  • Dr. Karel Dandurand – September 2020 – September 2021.
  • Dr. Yusuf Alalawi – July 2018 – July 2019.
  • Dr. Mohamed Almutairi – July 2016- June 2017.
  • Dr. Yasser Hakami – July 2015- June 2016.
  • Dr. Waleed Hashem – July 2014-July 2015.
  • Dr. Hatim Al-Alwani March 2022 – March 2023.
  • Dr. Abdulrahman Alamri September 2022 – 2023.

Goals of Training

Medical Expert

  1. Gain an in-depth understanding of bone biology and the mechanisms for the development of metabolic bone disease and calcium and parathyroid disorders.
  2. Be able to evaluate and diagnose and provide evidence-based management of complex metabolic bone diseases including fibrous dysplasia, sclerotic bone diseases, osteomalacia, osteogenesis imperfecta, hypophosphatasia, X-linked hypophosphatemia, renal osteodystrophy, premenopausal osteoporosis, Paget’s disease as well as calcium and parathyroid disorders.
  3. Become familiar with performing bone biopsies.
  4. Become certified by the ISCD in interpreting DXA (dual-energy x-ray absorptiometry) studies.
  5. Gain experience in interpreting DXA studies.

Collaborator

  1. Complete a clinical research project and publish it in a high-profile peer-reviewed journal.
  2. Complete inpatient and outpatient clinical assessments evaluating metabolic bone disease in all ages.
  3. Attend clinics and rounds and appreciate the value of the multidisciplinary team in addressing care issues.
  4. Attend journal clubs and endocrine rounds at McMaster University and the University of Toronto.
  5. Work effectively as a member of an interdisciplinary health care team.

Scholar and Communicator

  1. Present at citywide Endocrine Rounds as well as at Endocrine Journal club and at the Academic Half day.
  2. Educate patients and establish a therapeutic relationship with patients and family members.
  3. Educate health care professionals, medical students, and residents.
  4. Evaluate medical information and its sources critically and translate new knowledge into clinical practice and assist others in incorporating an evidence-based approach to clinical care.

Manager

  1. Wisely utilize the limited health care resources in inpatient care as well as outpatient care.
  2. Effectively partner with hospital and clinic resources in efficiently managing available services.
  3. Appreciate the value and role of audits and budget reviews.

Healthcare advocate

  1. Recognize health care requires support and being able to advocate for patients’ health care needs.
  2. Educate community members regarding measures which can prevent skeletal disease and improve skeletal health.
  3. Promote the health care needs of the public at risk of parathyroid and skeletal disease as well as patients’ needs.

Professional

  1. Understand and demonstrate principles of medical ethics as it relates to patient care.
  2. Be willing to accept peer and supervisor reviews of professional competence.

Length of Training

1 year

Expandable List

  1. Dandurand K, Ali DS, Khan AA. Barakat syndrome: a mini-series- oral presentation and Young
    investigator’s award winning, ASBMR 2021
  2. Ali DS, Dandurand K, Khan AA. Hypophosphatasia with a VUS Mutation of the ALPL Gene and Response to Asfotase Alfa: Case Report- accepted abstract, ASBMR 2021
  3. Van Umm S, Shrayyef M, M’Hiri I, Dandurand K, Ali DS, Bilezikian JP, Collins MT, Mannstadt M,. Rubin MR,Siggelkow H, Tabacco G, Donovan Tay YK, Vokes T, Winer KK, Yao L, Rejnmark L, Khan AA, Gordon Guyatt. Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: a Systematic Current Practice Survey- JBMR 2021, to be submitted
  4. Yao L, Hui X, Li J, Lin C, Kandi M, Sreekanta A, Li M, Makhdami N, Tamilselvan D, Ali DS, Dandurand K, Bilezikian JP, Brandi ML, Clarke B, Mannstadt M, Rejnmark L, Khan AA , on Guyatt G. Complications and symptoms in patients with chronic hypoparathyroidism: a systematic review- JBMR 2021, to be submitted
  5. Yao L, Li J, Lin C, Hui X, Tamilselvan D, Kandi M, Sreekanta A, Li M, Makhdami N, Ali DS, Dandurand K, Bilezikian JP, Brandi ML, Clarke B, Collins MT, Mannstadt M, Rejnmark L, Van Uum S, Khan AA, Guyatt G. Parathyroid hormone therapy for managing chronic hypoparathyroidism: a systematic review and meta-analysis- JBMR 2021, to be submitted
  6. Khan AA, Guyatt G, Ali DS, Bilezikian JP, Collins MT, Dandurand K, Mannstadt M, Murphy D, MR, Sanders R, Shrayyef M, Siggelkow H, Tabacco G, Donovan-Tay Y-, Van Uum S, Vokes T, Winer K, Yao L, Rejnmark L. Evaluation and Management of Hypoparathyroidism. – JBMR 2021, to be submitted
  7. Khan AA, Alrob H, Ali DS, Dandurand K, Wolfman W. SOGC clinical practice guideline: Menopause and Osteoporosis – JOCG 2021, accepted, to be published
  8. Dandurand K, Ali DS, Khan AA. Hypercalcemia in pregnancy – Hypercalcemia, An Issue of Endocrinology and Metabolism Clinics of North America, 1st Edition, to be released December 2021
  9. Khan A, Abu Alrob H, M’Hiri I, Hweija I, Said H, Iqbal S, Ali DS, Dandurand K, Brignardello-Petersen R. Effect of low dose denosumab on bone mineral density in postmenopausal women with osteoporosis; a prospective observational real-world study- submitted to OI, under review
  10. Ali DS, Dandurand K, Khan AA. Primary Hyperparathyroidism in Pregnancy Literature Review of the Diagnosis and Management. Journal of Clinical Medicine. 2021
  11. Dandurand K, Ali DS, Khan AA. Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management. Journal of Clinical Medicine. 2021; 10(8):1604. https://doi.org/10.3390/jcm10081604
  12. Ali DS, Dandurand K, Khan AA. Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management. Journal of Clinical Medicine. 2021; 10(7):1378. https://doi.org/10.3390/jcm10071378
  13. Dandurand K, Ali DS, Tran S, Zhou T Khan AA MD. Delayed Diagnosis of Congenital Hypoparathyroidism in a Kindred of Three Patients with Autosomal Dominant Deafness. Endocrine Society, Abstract, 2021.
  14. Ali DS, Dandurand K, Khan AA. Atypical presentation of Familial Hypocalciuric Hypercalcemia: a case report. Endocrine Society, Abstract, 2021.
  15. Khulod Almonaei IMH, Karel Dandurand, Dalal S. Ali, Hamza Syed, Aliya A. Khan. Fibrodysplasia Ossificans Progressiva (FOP) A Case Series. ASBMR Annual meeting 2021. Abstract 2021.

Curriculum Highlights

Clinics and Inpatient Responsibilities

Attend the following clinics

  • Monday a.m. – Calcium Disorders Clinic at the Boris Clinic MUMC
  • Monday p.m. – Metabolic Bone Clinic
  • Tuesday a.m.- dedicated research time
  • Tuesday p.m. – Metabolic Bone Clinic and inpatient consults OTMH
  • Wednesday all day – Metabolic Bone Clinic and inpatient consults OTMH
  • Thursday all day – Metabolic Bone Clinic and inpatient consults OTMH
  • Friday – dedicated research time

International Meetings

Attend and present at the American Society of Bone and Mineral Research annually as well as the International Society of Clinical Densitometry and The Endocrine Society.

Educational Rounds

Monthly attendance and participation in the Endocrine Grand Rounds, Journal Club, and Academic half-day in the department of Endocrinology and Metabolism.

Supervision & Feedback

Formal written assessments will be completed during the fellowship in the form of ITARs (In-Training Assessment Reports).